Page 51 - Pharma Sector

World Coronavirus Dispatch: EU vaccine makers seek immunity from lawsuits

Morgan Stanley turns cautious on bonds, why globalisation will survive, ozone's effectiveness in neutralising Covid, and other pandemic-related news across the globe

Pharmacy consolidation may disrupt domestic drug market: Credit Suisse

The report says if chemists are allowed to replace doctor's prescription with a generic drug, firms with high exposure to chronic therapeutic drugs will be impacted more

API segment supports growth for large generic pharma players in Q1

However, price correction could lead to growth moderation in the near term

Domestic pharma market to grow 12-14% in 3 years, exports by 8-14%: KPMG

The country ranks as the third-largest pharma market globally by volume and 13 largest by value

PE/VC investments drop 51% to $4.1 billion as big deals shrink in July

According to the IVCA-EY report, July recorded 10 large deals (value greater than $100 million) worth $3.1 billion compared to 13 large deals worth $7.1 billion in July 2019

Pharma rally may lose steam as valuations factor in near term gains

Recovery in India business, traction in new launches in the US market are needed to sustain gains

Domestic pharmaceutical industry to clock 4-6% growth in FY21: Icra

The domestic pharma industry has been posting slow growth numbers since March after the Covid-19 pandemic hit prescription generation

Rothschild bullish on India, expects to close more deals in H22020

Domestic deal activity managed to remain in the green during the first half, thanks to the unprecedented stake sale by Reliance Industries in Jio Platforms, between April and June, worth nearly $15 bn

Face-to-face selling hits a wall

By understanding the new normal, you can recalibrate your sales machine to become even more productive

Next 10 yrs to be India's golden moment: Silicon Valley venture capitalist

India has received foreign direct investment of over $20 billion in the last few months during the coronavirus pandemic

India needs holistic ecosystem to rebuild API manufacturing capacity: PwC

The Chinese API industry has an inherent advantage because of economies of scale and support from the Chinese government

MPs ask govt to promote inexpensive drugs, tighten reins on pharma lobby

A dozen of the 30 MPs, who are members of the parliamentary standing committee on home affairs, headed by Congress's Anand Sharma, attended the meeting

Green shoots seen in June pharma sales as domestic market grows 2.4%

The turn around follows deep decline in sales in the preceding months; July sales likely to be flat

Pharma SMEs will overcome short-term disruptions: CRISIL SME Tracker

Short-term disruptions include high input costs and various operational challenges.

Policy flip-flops may puncture India's image as 'pharmacy of the world'

India supplies almost 20 per cent of the medicines consumed by the world. Every third tablet in the US market is from India

Why India's automobile, pharma sectors are not ready to wean off China

India relies on China for products such as electronic components and drug ingredients because it cannot make them or source them elsewhere as cheap.

The discontents of decoupling

Economic delinking with China makes no sense for India; investment, growth and public welfare will suffer

Glenmark Pharma gets USFDA nod for drug to treat multiple sclerosis

The capsules are used in the treatment of adult patients with relapsing forms of multiple sclerosis

AstraZeneca Covid-19 vaccine to be shared across Europe, says France

The Netherlands also made clear on Monday that the vaccines would be available to all EU countries that sign up to the scheme after Belgium criticised the deal

With little access to doctors, drug firms go digital to stay relevant

The rise of e-pharmacies and tele-consultations during Covid-19 has made it easier for healthcare companies to access patient pools